Properties of an enzyme-based low-level iodine disinfectant.

An enzyme-based iodine (EBI) disinfectant that continuously generates free molecular iodine in a controlled fashion was developed and evaluated for use in disinfecting flexible fibreoptic endoscopes (FFEs). EBI is a powder concentrate that produces iodine from sodium iodide and calcium peroxide when catalyzed by horseradish peroxidase. After dissolution in water, it delivers relatively high concentrations of free molecular iodine (> 15 ppm) at relatively low concentrations of total iodine (30-40 ppm). It demonstrates the ability to function as an effective low level iodine disinfectant by rapidly inactivating bacteria, fungi and viruses. A unique feature of the EBI system is the ability to reoxidize reduced iodine which results in a constant level of active (free molecular) iodine during use. EBI inactivates Mycobacterium bovis var BCG more rapidly than 2% glutaraldehyde (Cidex-7). Its sporicidal activity, however, was found to be slower than the aldehyde formulation. The qualification of EBI for use as a practical disinfectant was shown by its negligible toxicity in dermal, ocular, oral and inhalation studies on animals, which is attributed to the low level of total iodine in the solution.

[1]  M. Ellett,et al.  SGNA endoscopic disinfectant survey. , 1995, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

[2]  J Holton,et al.  Efficacy of selected disinfectants against mycobacteria and cryptosporidia. , 1994, The Journal of hospital infection.

[3]  B. P. Dey,et al.  Neutralization of antimicrobial chemicals by recovery media , 1994 .

[4]  J. Furr,et al.  Antimycobacterial activity of 'Virkon'. , 1993, The Journal of hospital infection.

[5]  A. Streifel,et al.  Significant factors in the disinfection and sterilization of flexible endoscopes , 1992, American journal of infection control.

[6]  W. Rutala,et al.  Disinfection practices for endoscopes and other semicritical items. , 1991, Infection control and hospital epidemiology.

[7]  W A Rutala,et al.  APIC guideline for selection and use of disinfectants. , 1996, American journal of infection control.

[8]  W. Rutala,et al.  Effect of methodology, dilution, and exposure time on the tuberculocidal activity of glutaraldehyde-based disinfectants , 1990, Applied and environmental microbiology.

[9]  G. Ayliffe,et al.  Virucidal activity of disinfectants: studies with the poliovirus. , 1990, The Journal of hospital infection.

[10]  P. Burge Occupational risks of glutaraldehyde. , 1989, BMJ.

[11]  P. Blain,et al.  Occupational hazard in hospital staff exposed to 2 per cent glutaraldehyde in an endoscopy unit. , 1989, The Journal of the Society of Occupational Medicine.

[12]  J. M. Ascenzi,et al.  A more accurate method for measurement of tuberculocidal activity of disinfectants , 1987, Applied and environmental microbiology.

[13]  R. Davies,et al.  Asthma and Rhinitis after Exposure to Glutaraldehyde in Endoscopy Units , 1986, Human toxicology.

[14]  W. Gottardi Potentiometrische Bestimmung der Gleichgewichtskonzentrationen an freiem und komplex gebundenem Iod in wÄ\rigen Lösungen von Polyvinylpyrrolidon-Iod (PVP-Iod) , 1983 .

[15]  M. Favero Iodine—Champagne in a Tin Cup , 1982, Infection Control.

[16]  S. Gorman,et al.  Antimicrobial activity, uses and mechanism of action of glutaraldehyde. , 1980, The Journal of applied bacteriology.

[17]  W. Horwitz Official Methods of Analysis , 1980 .

[18]  A. Glazer,et al.  Chemical modification of proteins: Selected methods and analytical procedures , 1975 .

[19]  T. Bergan,et al.  Antitubercular action of disinfectants. , 1971, The Journal of applied bacteriology.

[20]  Persis Mehta,et al.  Disinfection of medical and surgical materials. , 1971, American journal of hospital pharmacy.